Celldex Therapeutics reported $6.08M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Amgen USD 1.69B 4M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Celldex Therapeutics USD 6.08M 4.74M Jun/2025
Glaxosmithkline GBP 2.09B 609M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024